Stay updated on Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A site-wide NIH notice appears above the ClinicalTrials.gov navigation, announcing a website transition and changes in terminology around artificial intelligence.
    Difference
    1%
    Check dated 2026-10-25T17:07:48.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2 while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T20:56:57.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer site revision changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T21:53:03.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the expected study record content and showing only the site header and footer.
    Difference
    0.5%
    Check dated 2026-09-27T20:39:48.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The study page is replaced with a 403 Forbidden error, preventing access to the study record content and associated navigation. This indicates that access to the study information is currently restricted.
    Difference
    20%
    Check dated 2026-09-20T20:33:58.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision v3.6.6 has been released, replacing the previous v3.6.5. This appears to be a routine backend update that does not affect the displayed study details.
    Difference
    0.1%
    Check dated 2026-08-30T20:52:39.000Z thumbnail image

Stay in the know with updates to Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page.